<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d663">
    <sentence id="DDI-DrugBank.d663.s0" text="Drug interaction studies have not been conducted with LUCENTIS. ">
        <entity id="DDI-DrugBank.d663.s0.e0" charOffset="54-61"
            type="brand" text="LUCENTIS"/>
    </sentence>
    <sentence id="DDI-DrugBank.d663.s1" text="LUCENTIS intravitreal injection has been used adjunctively with verteporfin photodynamic therapy (PDT). ">
        <entity id="DDI-DrugBank.d663.s1.e0" charOffset="0-7"
            type="brand" text="LUCENTIS"/>
        <entity id="DDI-DrugBank.d663.s1.e1" charOffset="64-74"
            type="drug" text="verteporfin"/>
        <pair id="DDI-DrugBank.d663.s1.p0" e1="DDI-DrugBank.d663.s1.e0"
            e2="DDI-DrugBank.d663.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d663.s2" text="Twelve of 105 (11%) patients developed serious intraocular inflammation; "/>
    <sentence id="DDI-DrugBank.d663.s3" text="in 10 of the 12 patients, this occurred when LUCENTIS was administered 7 days (   2 days) after verteporfin PDT.">
        <entity id="DDI-DrugBank.d663.s3.e0" charOffset="45-52"
            type="brand" text="LUCENTIS"/>
        <entity id="DDI-DrugBank.d663.s3.e1" charOffset="96-106"
            type="drug" text="verteporfin"/>
        <pair id="DDI-DrugBank.d663.s3.p0" e1="DDI-DrugBank.d663.s3.e0"
            e2="DDI-DrugBank.d663.s3.e1" ddi="false"/>
    </sentence>
</document>
